Gastrointestinal and Pancreatic Cancer Program

Medical Director: J. Marc Pipas, MD
Scientific Director, Pancreas Program: Murray Korc, MD

The Gastrointestinal and Pancreatic Cancer Program provides multidisciplinary review of all gastrointestinal cancer cases arising from the following sites: esophagus, stomach, small intestine, colon, rectum, anus, liver, and pancreas. The program integrates research protocol opportunities with established treatment algorithms, and evaluates new research ideas and clinical therapies for the treatment of patients with gastrointestinal cancers.

Read the Focus (Winter 2009) article, "Murray Korc: Putting Principles into Practice," which explains how the team brings new treatments from the lab bench to the hospital bed to improve patients' lives.

Special Services and Diagnostic Tests:

• Intraoperative radiation therapy
• Endoscopic ultrasound and biopsy techniques for staging of gastrointestinal cancers
• Chemo-embolization of unresectable liver malignancies
• Radiofrequency ablation of liver malignancies
• Liver, bile duct, pancreatic, sarcoma, and esophageal surgery

• Neoadjuvant chemotherapy and radiation therapy for pancreatic and esophageal cancers
• Chemoprevention of colon cancer
• Neoadjuvant chemotherapy and radiation therapy for sarcomas
• Phase I agents for multiple histologic tumor types